Tucker Asset Management LLC Lantern Pharma Inc. Transaction History

Tucker Asset Management LLC

  • $458 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024
SELL
$3.91 - $9.51 $44,965 - $109,365
-11,500 Closed
0 $0
Q1 2024

Aug 09, 2024
BUY
$3.73 - $10.65 $42,895 - $122,475
11,500 New
11,500 $101 Million

Others Institutions Holding LTRN

# of Institutions
41
Shares Held
1.26M
Call Options Held
42.8K
Put Options Held
5.6K
View Full List

About Lantern Pharma Inc.

LTRN Quotes by TradingView
  • Ticker LTRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 10,830,900
  • Market Cap $40.9M
  • Description
  • Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...
More about LTRN
Track This Portfolio

Track Tucker Asset Management LLC Portfolio

Follow Tucker Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tucker Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tucker Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email